# Drug Synergy Prediction - Implementation Plan

**Project**: Attention-Based Multi-Modal Fusion for Drug Synergy Prediction  
**Start Date**: January 2026  
**Duration**: 6 Weeks

---

## Phase 1: Evaluation & Baseline (Week 1)

| Task | Status | Notes |
|------|--------|-------|
| Implement end-to-end SynergyModel with attention fusion | Done | `src/models/synergy_model.py` |
| Train on DrugComb dataset | Done | Val MSE: 13.40 |
| Evaluate on test set with comprehensive metrics | Pending | MAE, R², Pearson, Spearman |
| Compare against simple MLP baseline (concatenation) | Pending | Use existing `SynergyMLP` |
| Analyze attention weights for interpretability | Pending | Extract from cross-attention |

**Deliverables**:
- Test set evaluation report
- Baseline comparison table
- Attention visualization notebook

---

## Phase 2: Model Improvements (Week 2-3)

| Task | Status | Priority |
|------|--------|----------|
| Implement target standardization | Pending | High |
| Add learning rate scheduling (CosineAnnealing) | Pending | High |
| Multi-task learning for all synergy metrics | Pending | High |
| Hyperparameter tuning (hidden dims, attention heads, dropout) | Pending | Medium |
| Cross-validation for robust performance estimates | Pending | Medium |
| Add early stopping | Pending | Medium |
| Implement gradient clipping | Pending | Low |

**Hyperparameters to Tune**:
```
- Learning rate: [1e-5, 5e-5, 1e-4, 5e-4]
- Batch size: [32, 64, 128]
- Hidden dimension: [256, 512, 1024]
- Attention heads: [4, 8, 16]
- Dropout: [0.1, 0.2, 0.3]
- Weight decay: [0, 1e-5, 1e-4]
```

**Deliverables**:
- Hyperparameter sweep results
- Multi-task model checkpoint
- Updated training curves

---

## Phase 3: Advanced Features (Week 4-5)

| Task | Status | Priority |
|------|--------|----------|
| Implement drug pair symmetry augmentation | Pending | High |
| Add GNN-based drug encoder option (e.g., MPNN) | Pending | Medium |
| Stacked transformer layers for deeper fusion | Pending | Medium |
| Implement Mixup data augmentation | Pending | Low |
| Cell line embedding via graph (if data available) | Pending | Low |
| Ensemble multiple models | Pending | Low |

**Architecture Experiments**:
```
1. Deeper omics encoder (3-4 layers with residual)
2. Separate drug-drug interaction module
3. Multiple cross-attention layers (2-3 stacked)
4. Replace mean pooling with [CLS] token
```

**Deliverables**:
- Ablation study on architecture variants
- Best performing model checkpoint
- Comparison table of all experiments

---

## Phase 4: Analysis & Documentation (Week 6)

| Task | Status | Priority |
|------|--------|----------|
| Comprehensive ablation studies | Pending | High |
| Interpretability analysis (attention visualization) | Pending | High |
| Error analysis on prediction failures | Pending | High |
| Case studies on known synergistic pairs | Pending | Medium |
| Final paper preparation | Pending | High |
| Code cleanup and documentation | Pending | Medium |

**Analysis Questions**:
1. Which omics modality contributes most to predictions?
2. Do attention patterns differ for synergistic vs antagonistic pairs?
3. What drug/cell line combinations have highest prediction error?
4. How does performance vary across different cancer types?

**Deliverables**:
- Final technical report/paper
- Supplementary materials (figures, tables)
- Clean, documented codebase
- Model weights and reproducibility scripts

---

## Timeline Summary

```
Week 1  [■■■■■■■■■■] Phase 1: Evaluation & Baseline
Week 2  [■■■■■□□□□□] Phase 2: Model Improvements (Part 1)
Week 3  [□□□□□■■■■■] Phase 2: Model Improvements (Part 2)
Week 4  [■■■■■■■□□□] Phase 3: Advanced Features (Part 1)
Week 5  [□□□■■■■■■■] Phase 3: Advanced Features (Part 2)
Week 6  [■■■■■■■■■■] Phase 4: Analysis & Documentation
```

---

## Current Progress

### Completed
- [x] Dataset preparation (DrugComb splits)
- [x] Drug embeddings (MolFormer-XL)
- [x] SynergyModel architecture
- [x] End-to-end training pipeline
- [x] Initial training run (100 epochs)

### Current Results
| Metric | Value |
|--------|-------|
| Best Val MSE | 13.40 |
| Final Train MSE | 11.66 |
| Total Parameters | 20.4M |
| Training Time | ~1.7 hours (100 epochs) |

### Next Immediate Actions
1. Run test set evaluation
2. Implement target standardization
3. Add learning rate scheduler
4. Set up multi-task learning

---

## Files Reference

| File | Description |
|------|-------------|
| `main.py` | Training script |
| `src/models/synergy_model.py` | Model architecture |
| `src/dataset.py` | Dataset classes |
| `src/models/mlp.py` | Baseline MLP |
| `logs/synergy_attn_*/` | Training logs and checkpoints |
| `data/models/` | Saved model weights |

---

## Notes

- Target column: `Synergy_ZIP` (can extend to Bliss, Loewe, HSA)
- Drug embeddings are frozen (from MolFormer)
- Omics encoder is trainable
- BatchNorm applied to omics inputs for stability
